Rethinking the Psychosis Threshold in Clinical High Risk

Affiliations

¹ Department of Medicine, Division of Psychiatry, University of Perugia, Perugia, Italy.
² Department of Mental Health, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
³ Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD.

Editorial

Andrea Raballo et al. Schizophr Bull. 2019.

. 2019 Jan 1;45(1):1-2.

doi: 10.1093/schbul/sby149.

¹ Department of Medicine, Division of Psychiatry, University of Perugia, Perugia, Italy.
² Department of Mental Health, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
³ Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD.

No abstract available

References

1. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353–370. - PubMed
1. Fusar-Poli P, Cappucciati M, Borgwardt S, et al. . Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry. 2016;73:113–120. - PubMed
1. van Os J, Guloksuz S. A critique of the “ultra-high risk” and “transition” paradigm. World Psychiatry. 2017;16:200–206. - PMC - PubMed
1. Carpenter WT. Clinical high risk controversies and challenge for the experts. Schizophr Bull. 2018;44:223–225. - PMC - PubMed
1. Hengartner MP, Heekeren K, Dvorsky D, Walitza S, Rössler W, Theodoridou A. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: results of a longitudinal observation study over three years focusing on both converters and non-converters. Schizophr Res. 2017;189:19–26. - PubMed